Verified Document

FDA Drug Review Process Case Study

Clinical Protocol Differences The author of this response is asked to do a few things from a research standpoint. After which, the author shall answer a question related to the activities completed. First, the author of this response is to conduct a literature review about the protocols and methods used to develop a new drug and get it approved by the Food and Drug Administration and other relevant regulatory bodies. Second, the author is asked to a similar review but one that pertains to studies and research that is simply meant to add to the knowledge base that exists in the medical and clinical sphere. The author must then consider the differences and similarities between the two and summarize that in the form of the author's discussion response.

Summary

Both knowledgebase studies and drug approval processes have one major similarity and that is to advance the field of medical science. The field is all about saving lives, prolonging lives and helping everyone around the world in terms of medical care and quality of life. However, there is one stark difference between knowledgebase studies and those that pertain to drugs. When it comes to drugs and their approval, people will be taking those drugs. Drugs...

When it comes to knowledgebase articles, the stakes are rarely that high.
For example, if drug A is being considered for approval, there are extensive tests and trials. Those tests are done to ensure and verify whether the drug treats the diseases and/or disorders that it is meant to treat. At the same time, it has be verified whether there are any health risks involved. Anyone who has read the potential or likely side effect list for a drug knows those lists can be very extensive. Even approved and commonly used drugs come with major warnings and/or restrictions and the perceived or actual effects of taking those drugs are often fodder for trial lawyers that only see dollar signs (Berenson, 2003).

By contrast, knowledgebase articles are typically more benign. For sure, they could pertain to drugs and their effects but they are typically drugs that are already approved and commonly used. Other knowledgebase article relate to things that are somewhat removed from the medical care itself including the knowledge, perception and feelings of patients and practitioners. Other times,…

Sources used in this document:
References

Berenson, A. (2015). Trial Lawyers Are Now Focusing On Lawsuits Against Drug Makers. Nytimes.com. Retrieved 2 July 2015, from http://www.nytimes.com/2003/05/18/us/trial-lawyers-are-now-focusing-on-lawsuits-against-drug-makers.html

Voight, M. (2012). PUBLISHING YOUR WORK IN A JOURNAL: UNDERSTANDING THE PEER REVIEW PROCESS. International Journal Of Sports Physical Therapy, 7(5), 452. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474310/
Cite this Document:
Copy Bibliography Citation

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now